位置:首页 > 蛋白库 > CBPC2_MOUSE
CBPC2_MOUSE
ID   CBPC2_MOUSE             Reviewed;         862 AA.
AC   Q8CDK2; A2AH35; Q09M08; Q09M09; Q09M10; Q09M11; Q09M12; Q8C529; Q8C9X4;
AC   Q8CDE6; Q8CDF6; Q8CDQ1;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=Cytosolic carboxypeptidase 2 {ECO:0000303|PubMed:25103237};
DE            EC=3.4.17.- {ECO:0000269|PubMed:25103237};
DE   AltName: Full=ATP/GTP-binding protein-like 2;
DE   AltName: Full=Protein deglutamylase CCP2 {ECO:0000305};
GN   Name=Agbl2 {ECO:0000312|MGI:MGI:2443254};
GN   Synonyms=Ccp2 {ECO:0000303|PubMed:25103237};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5), FUNCTION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BLKS/J;
RX   PubMed=17244818; DOI=10.1096/fj.06-7329com;
RA   Kalinina E., Biswas R., Berezniuk I., Hermoso A., Aviles F.X.,
RA   Fricker L.D.;
RT   "A novel subfamily of mouse cytosolic carboxypeptidases.";
RL   FASEB J. 21:836-850(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 6 AND 7).
RC   STRAIN=C57BL/6J; TISSUE=Testis, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, INDUCTION, DISRUPTION
RP   PHENOTYPE, AND MUTAGENESIS OF GLU-593.
RX   PubMed=25103237; DOI=10.1091/mbc.e14-06-1072;
RA   Tort O., Tanco S., Rocha C., Bieche I., Seixas C., Bosc C., Andrieux A.,
RA   Moutin M.J., Aviles F.X., Lorenzo J., Janke C.;
RT   "The cytosolic carboxypeptidases CCP2 and CCP3 catalyze posttranslational
RT   removal of acidic amino acids.";
RL   Mol. Biol. Cell 25:3017-3027(2014).
CC   -!- FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of
CC       tubulin and non-tubulin target proteins (PubMed:25103237). Catalyzes
CC       the removal of polyglutamate side chains present on the gamma-carboxyl
CC       group of glutamate residues within the C-terminal tail of tubulin
CC       protein (PubMed:25103237). Specifically cleaves tubulin long-side-
CC       chains, while it is not able to remove the branching point glutamate
CC       (PubMed:25103237). Also catalyzes the removal of polyglutamate residues
CC       from the carboxy-terminus of non-tubulin proteins such as MYLK
CC       (PubMed:25103237). {ECO:0000269|PubMed:25103237}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(L-glutamyl)(n+1)-gamma-L-glutamyl-L-glutamyl-[protein] + H2O
CC         = (L-glutamyl)(n)-gamma-L-glutamyl-L-glutamyl-[protein] + L-
CC         glutamate; Xref=Rhea:RHEA:60004, Rhea:RHEA-COMP:15519, Rhea:RHEA-
CC         COMP:15675, ChEBI:CHEBI:15377, ChEBI:CHEBI:29985, ChEBI:CHEBI:143623;
CC         Evidence={ECO:0000269|PubMed:25103237};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60005;
CC         Evidence={ECO:0000305|PubMed:25103237};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Inhibited by RARRES1. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with RARRES1, KIF11 AND MAPRE1.
CC       {ECO:0000250|UniProtKB:Q5U5Z8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17244818}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome,
CC       centriole {ECO:0000250|UniProtKB:Q5U5Z8}. Cytoplasm, cytoskeleton,
CC       cilium basal body {ECO:0000250|UniProtKB:Q5U5Z8}. Note=Colocalizes with
CC       gamma-tubulin in the centrioles and with glutamylated tubulin in the
CC       basal bodies of ciliated cells. {ECO:0000250|UniProtKB:Q5U5Z8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q8CDK2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8CDK2-2; Sequence=VSP_024366, VSP_024368;
CC       Name=3;
CC         IsoId=Q8CDK2-3; Sequence=VSP_024367, VSP_024369;
CC       Name=4;
CC         IsoId=Q8CDK2-4; Sequence=VSP_024365;
CC       Name=5;
CC         IsoId=Q8CDK2-5; Sequence=VSP_024364, VSP_024365;
CC       Name=6;
CC         IsoId=Q8CDK2-6; Sequence=VSP_024363, VSP_024366, VSP_024368;
CC       Name=7;
CC         IsoId=Q8CDK2-7; Sequence=VSP_024362, VSP_024367, VSP_024369;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in tissues with motile
CC       cilia such as testis, lung and trachea. Also detected in brain, eye,
CC       muscle, pancreas, intestine, stomach, pituitary, spleen, adrenal and
CC       kidney. Expressed in mitral and granular cells in brain.
CC       {ECO:0000269|PubMed:17244818, ECO:0000269|PubMed:25103237}.
CC   -!- INDUCTION: Up-regulated during ciliogenesis.
CC       {ECO:0000269|PubMed:25103237}.
CC   -!- DISRUPTION PHENOTYPE: AGBL2 and AGBL3 double mutants are viable and
CC       display no obvious phenotypic alterations.
CC       {ECO:0000269|PubMed:25103237}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the peptidase M14 family. {ECO:0000305}.
CC   -!- CAUTION: Was initially shown to catalyze the removal of carboxy-
CC       terminus tyrosine from alpha-tubulin (By similarity). However, later
CC       studies did not identified any detyrosinase or deglycylase activities
CC       from the carboxy-terminus of tubulin (PubMed:25103237).
CC       {ECO:0000250|UniProtKB:Q5U5Z8, ECO:0000269|PubMed:25103237}.
CC   -!- CAUTION: Was originally thought to have detyrosinating activity from C-
CC       terminal positions on tubulin. {ECO:0000250|UniProtKB:Q5U5Z8}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABI51945.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=ABI51946.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=ABI51947.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=ABI51948.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=ABI51949.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC37726.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAM20823.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ867026; ABI51945.1; ALT_INIT; mRNA.
DR   EMBL; DQ867027; ABI51946.1; ALT_INIT; mRNA.
DR   EMBL; DQ867028; ABI51947.1; ALT_INIT; mRNA.
DR   EMBL; DQ867029; ABI51948.1; ALT_INIT; mRNA.
DR   EMBL; DQ867030; ABI51949.1; ALT_INIT; mRNA.
DR   EMBL; AK029744; BAC26594.1; -; mRNA.
DR   EMBL; AK029932; BAC26686.1; -; mRNA.
DR   EMBL; AK030138; BAC26802.1; -; mRNA.
DR   EMBL; AK030182; BAC26827.1; -; mRNA.
DR   EMBL; AK040259; BAC30555.2; -; mRNA.
DR   EMBL; AK079691; BAC37726.2; ALT_INIT; mRNA.
DR   EMBL; AL714026; CAM20823.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL714026; CAM20824.1; -; Genomic_DNA.
DR   EMBL; AL714026; CAM20825.1; -; Genomic_DNA.
DR   CCDS; CCDS38177.2; -. [Q8CDK2-1]
DR   CCDS; CCDS89512.1; -. [Q8CDK2-6]
DR   RefSeq; NP_848870.2; NM_178755.3. [Q8CDK2-1]
DR   RefSeq; XP_006499695.1; XM_006499632.2. [Q8CDK2-1]
DR   RefSeq; XP_006499703.1; XM_006499640.1. [Q8CDK2-4]
DR   RefSeq; XP_006499704.1; XM_006499641.3.
DR   RefSeq; XP_006499705.1; XM_006499642.3. [Q8CDK2-2]
DR   RefSeq; XP_006499706.1; XM_006499643.1. [Q8CDK2-5]
DR   RefSeq; XP_011237881.1; XM_011239579.1. [Q8CDK2-5]
DR   AlphaFoldDB; Q8CDK2; -.
DR   SMR; Q8CDK2; -.
DR   STRING; 10090.ENSMUSP00000129216; -.
DR   MEROPS; M14.029; -.
DR   iPTMnet; Q8CDK2; -.
DR   PhosphoSitePlus; Q8CDK2; -.
DR   MaxQB; Q8CDK2; -.
DR   PaxDb; Q8CDK2; -.
DR   PRIDE; Q8CDK2; -.
DR   ProteomicsDB; 283690; -. [Q8CDK2-1]
DR   ProteomicsDB; 283691; -. [Q8CDK2-2]
DR   ProteomicsDB; 283692; -. [Q8CDK2-3]
DR   ProteomicsDB; 283693; -. [Q8CDK2-4]
DR   ProteomicsDB; 283694; -. [Q8CDK2-5]
DR   ProteomicsDB; 283695; -. [Q8CDK2-6]
DR   ProteomicsDB; 283696; -. [Q8CDK2-7]
DR   Antibodypedia; 1166; 123 antibodies from 22 providers.
DR   DNASU; 271813; -.
DR   Ensembl; ENSMUST00000037206; ENSMUSP00000047936; ENSMUSG00000040812. [Q8CDK2-6]
DR   Ensembl; ENSMUST00000037219; ENSMUSP00000048647; ENSMUSG00000040812. [Q8CDK2-1]
DR   Ensembl; ENSMUST00000051831; ENSMUSP00000051620; ENSMUSG00000040812. [Q8CDK2-3]
DR   Ensembl; ENSMUST00000111481; ENSMUSP00000107106; ENSMUSG00000040812. [Q8CDK2-1]
DR   Ensembl; ENSMUST00000170320; ENSMUSP00000129216; ENSMUSG00000040812. [Q8CDK2-1]
DR   GeneID; 271813; -.
DR   KEGG; mmu:271813; -.
DR   UCSC; uc008ktc.2; mouse. [Q8CDK2-6]
DR   UCSC; uc008ktd.2; mouse. [Q8CDK2-2]
DR   UCSC; uc008kte.2; mouse. [Q8CDK2-1]
DR   UCSC; uc008ktg.2; mouse. [Q8CDK2-4]
DR   UCSC; uc008kth.2; mouse. [Q8CDK2-5]
DR   UCSC; uc008ktk.1; mouse. [Q8CDK2-7]
DR   CTD; 79841; -.
DR   MGI; MGI:2443254; Agbl2.
DR   VEuPathDB; HostDB:ENSMUSG00000040812; -.
DR   eggNOG; KOG3641; Eukaryota.
DR   GeneTree; ENSGT00940000160201; -.
DR   InParanoid; Q8CDK2; -.
DR   OMA; TDVVLYC; -.
DR   OrthoDB; 481670at2759; -.
DR   PhylomeDB; Q8CDK2; -.
DR   TreeFam; TF313794; -.
DR   BioGRID-ORCS; 271813; 0 hits in 72 CRISPR screens.
DR   ChiTaRS; Agbl2; mouse.
DR   PRO; PR:Q8CDK2; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q8CDK2; protein.
DR   Bgee; ENSMUSG00000040812; Expressed in spermatocyte and 42 other tissues.
DR   ExpressionAtlas; Q8CDK2; baseline and differential.
DR   GO; GO:0005814; C:centriole; ISS:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0004181; F:metallocarboxypeptidase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0035610; P:protein side chain deglutamylation; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   InterPro; IPR040626; Pepdidase_M14_N.
DR   InterPro; IPR000834; Peptidase_M14.
DR   Pfam; PF18027; Pepdidase_M14_N; 1.
DR   Pfam; PF00246; Peptidase_M14; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carboxypeptidase; Cell projection; Cytoplasm;
KW   Cytoskeleton; Hydrolase; Metal-binding; Metalloprotease; Protease;
KW   Reference proteome; Zinc.
FT   CHAIN           1..862
FT                   /note="Cytosolic carboxypeptidase 2"
FT                   /id="PRO_0000283750"
FT   REGION          669..692
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          704..728
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          750..836
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        672..690
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        750..787
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        807..829
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        475
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P00730"
FT   BINDING         425
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q09M02"
FT   BINDING         428
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q09M02"
FT   BINDING         521
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P00730"
FT   VAR_SEQ         1..298
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_024362"
FT   VAR_SEQ         2..12
FT                   /note="NVLLEMAFLSQ -> FPALETELKPE (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_024363"
FT   VAR_SEQ         79..97
FT                   /note="WPTCLSSTGHAHIDAVNRD -> Y (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17244818"
FT                   /id="VSP_024364"
FT   VAR_SEQ         744..779
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17244818"
FT                   /id="VSP_024365"
FT   VAR_SEQ         806..809
FT                   /note="SKKP -> GFST (in isoform 2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_024366"
FT   VAR_SEQ         807..836
FT                   /note="KKPGFTASCSPKRSTNSSLGPAPDVKPNWS -> YSQPCVFSLILHEHQAQT
FT                   SSDTPCQNPESH (in isoform 3 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_024367"
FT   VAR_SEQ         810..862
FT                   /note="Missing (in isoform 2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_024368"
FT   VAR_SEQ         837..862
FT                   /note="Missing (in isoform 3 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:17244818"
FT                   /id="VSP_024369"
FT   MUTAGEN         593
FT                   /note="E->A: Abolishes deglutamylase activity."
FT                   /evidence="ECO:0000269|PubMed:25103237"
FT   CONFLICT        134
FT                   /note="S -> F (in Ref. 2; BAC26827)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        146
FT                   /note="I -> L (in Ref. 2; BAC26827)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        206
FT                   /note="R -> T (in Ref. 2; BAC26827)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        749
FT                   /note="V -> F (in Ref. 2; BAC26827)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   862 AA;  99216 MW;  B532FEB80F6A8D04 CRC64;
     MNVLLEMAFL SQTLPDPYED FIHHHLQYYG YFKAQKSSLP NSGTHQRVWR NSPRYMLNGS
     FGERDDFISD SLEKEMLLWP TCLSSTGHAH IDAVNRDSLL LSSPLLRTRQ LIFDELDEAS
     PRLREPRELF SCFSSRGPLQ APRWPIECEV IKENIHHIEW VPHQPEYFYQ PTGSEKVPEI
     VGEEQGTVVY QLDSVPAEGT YFTSSRIGGK RGTIKELAVT LQGPDDNTLL FESRFESGNL
     QKAVRVGIYE YELTLRTDLY TDKHTQWFYF RVQNTRKDAT YRFTIVNLLK PKSLYAVGMK
     PLMYSQLDAT IYNIGWRREG REIKYYKNNV DDGQQPLYCL TWTTQFPHDQ DTCFFAHFYP
     YTYTDLQCYL LSVANNPIQS QFCKLRALCR SLAGNTVYLL TITNPSRTPQ EAAAKKAVVL
     SARVHPGESN SSWIMNGFLD FILSNSPDAQ LLRDIFVFKV IPMLNPDGVI VGNYRCSLAG
     RDLNRHYKTV LKDSFPCIWY TKNMIKRLLE EREVLLYCDF HGHSRKNNIF LYGCHSNNRK
     HWLHERVFPL MLSKNAPDKF SFDSCNFKVQ KCKEGTGRVV MWRMGIINSY TMESTFGGST
     LGSKRDTHFT IEDLKSLGYH VCDTLLDFCD PDQTKYTQCL QELKELLQQE INKKLNNFGQ
     DMDLEGNWSD IPLSDIESST SGSDSSLSDG PPIRLLNIVA DEPNQKTVLK NPKKKRLQTR
     KQRNEQYQKS YLMRELKLTE NAPGRARFVS TLQKQPTFLK SPESPSPSVR RSENPRLNET
     QLSGREKGTS LDPPLTSPKN KERIQSKKPG FTASCSPKRS TNSSLGPAPD VKPNWSKTRY
     SATRKDHATM AVYPSLHIYT YP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025